Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view.
Meinag FE, Fatahi M, Vahedian V, Maroufi NF, Mosayyebi B, Ahmadi E, Rahmati M.
Funct Integr Genomics. 2024 Sep 2;24(5):150. doi: 10.1007/s10142-024-01431-x.
Molecular mechanisms of multidrug resistance in cancer chemotherapy.
Nooter K, Stoter G.
Pathol Res Pract. 1996 Jul;192(7):768-80. doi: 10.1016/S0344-0338(96)80099-9.
Evaluation of minimal disseminated disease in cryopreserved ovarian tissue from bone and soft tissue sarcoma patients.
Dolmans MM, Iwahara Y, Donnez J, Soares M, Vaerman JL, Amorim CA, Poirel H.
Hum Reprod. 2016 Oct;31(10):2292-302. doi: 10.1093/humrep/dew193. Epub 2016 Sep 2.
Clinical significance of cytogenetic findings in solid tumors.
Mitelman F, Johansson B, Mandahl N, Mertens F.
Cancer Genet Cytogenet. 1997 May;95(1):1-8. doi: 10.1016/s0165-4608(96)00252-x.
Mechanomimetic 3D Scaffolds as a Humanized In Vitro Model for Ovarian Cancer.
Paradiso F, Lenna S, Gazze SA, Garcia Parra J, Murphy K, Margarit L, Gonzalez D, Francis L, Taraballi F.
Cells. 2022 Feb 26;11(5):824. doi: 10.3390/cells11050824.
Ovarian tissue cryopreservation for cancer patients: who is appropriate?
Seymour JF.
Reprod Fertil Dev. 2001;13(1):81-9. doi: 10.1071/rd00075.
Cancer incidence patterns among adolescents and young adults in the United States.
Wu X, Groves FD, McLaughlin CC, Jemal A, Martin J, Chen VW.
Cancer Causes Control. 2005 Apr;16(3):309-20. doi: 10.1007/s10552-004-4026-0.
Elevated serum chromogranin A is detectable in patients with carcinomas at advanced disease stages.
Wu JT, Erickson AJ, Tsao KC, Wu TL, Sun CF.
Ann Clin Lab Sci. 2000 Apr;30(2):175-8.
Relative frequency and morphology of cancers in carriers of germline TP53 mutations.
Birch JM, Alston RD, McNally RJ, Evans DG, Kelsey AM, Harris M, Eden OB, Varley JM.
Oncogene. 2001 Aug 2;20(34):4621-8. doi: 10.1038/sj.onc.1204621.
Multimodality expression profiling shows SEPT9 to be overexpressed in a wide range of human tumours.
Scott M, Hyland PL, McGregor G, Hillan KJ, Russell SE, Hall PA.
Oncogene. 2005 Jul 7;24(29):4688-700. doi: 10.1038/sj.onc.1208574.
